Tang Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,814,000
Closed -$25.4M 78
2025
Q4
$25.4M Sell
2,814,000
-286,000
-9% -$2.14M 1.26% 21
2025
Q3
$9.64M Hold
3,100,000
0.37% 66
2025
Q2
$6.63M Hold
3,100,000
0.34% 71
2025
Q1
$3.56M Hold
3,100,000
0.2% 90
2024
Q4
$6.79M Hold
3,100,000
0.45% 61
2024
Q3
$6.76M Hold
3,100,000
0.48% 60
2024
Q2
$7.16M Hold
3,100,000
0.73% 43
2024
Q1
$17.1M Buy
3,100,000
+1,100,000
+55% +$5.03M 1.78% 16
2023
Q4
$4.94M Buy
+2,000,000
New +$19M 0.46% 57

Other funds holding VTYX

Tang Capital Management's VTYX Position: Q1 2026 in Review

Tang Capital Management sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 2,814,000 shares — an estimated $25.4M sold.

Tang Capital Management first reported a position in VTYX in Q4 2023 and held it in 9 quarters. The position peaked at $25.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Tang Capital Management reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Tang Capital Management sold 2,814,000 Ventyx Biosciences shares in Q1 2026, an estimated $25.4M.
  • Tang Capital Management first reported a position in Ventyx Biosciences in Q4 2023 and held it in 9 quarters.
  • Tang Capital Management's Ventyx Biosciences position peaked at $25.4M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.